Skip to main content

Advertisement

Log in

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive disease caused by mutations of the AutoImmune REgulator gene. The clinical spectrum of the disease encompasses several autoimmune endocrine and non-endocrine manifestations, which may lead to acute metabolic alterations and eventually life-threatening events. The clinical diagnosis is defined by the presence of at least two components of the classic triad including chronic mucocoutaneous candidiasis (CMC), chronic hypoparathyroidism (CH), Addison’s disease (AD). Other common features of the disease are hypergonadotropic hypogonadism, alopecia, vitiligo, autoimmune hepatitis, Type 1 diabetes, gastrointestinal dysfunction. APECED usually begins in childhood. CMC is the first manifestation to appear, usually before the age of 5 yr, followed by CH and then by AD. The clinical phenotype may evolve over several years and many components of the disease may not appear until the 4th or 5th decade of life. The phenotypical expression of the syndrome shows a wide variability even between siblings with the same genotype. In view of this heterogeneity, an early diagnosis of APECED can be very challenging often leading to a considerable diagnostic delay. Therefore, clinicians should be aware that the presence of even a minor component of APECED in children should prompt a careful investigation for other signs and symptoms of the disease, thus allowing an early diagnosis and prevention of severe and life-threatening events. Aim of this review is to focus on clinical presentation, diagnosis and management of the major components of APECED in children particularly focusing on endocrine features of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997, 17: 399–403.

    Article  Google Scholar 

  2. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009, 27: 287–312.

    Article  PubMed  CAS  Google Scholar 

  3. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet 1997, 17: 393–8.

    Article  PubMed  CAS  Google Scholar 

  4. Aaltonen J, Horelli-Kuitunen N, Fan JB, et al. High-resolution physical and transcriptional mapping of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy locus on chromosome 21q22.3 by FISH. Genome Res 1997, 7: 820–9.

    PubMed  CAS  Google Scholar 

  5. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298: 1395–401.

    Article  PubMed  CAS  Google Scholar 

  6. Gardner JM, Devoss JJ, Friedman RS, et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008, 321: 843–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Abramson J, Giraud M, Benoist C, Mathis D. Aire’s partners in the molecular control of immunological tolerance. Cell 2010, 140: 123–35.

    Article  PubMed  CAS  Google Scholar 

  8. Gallo V, Giardino G, Capalbo D, et al. Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model. Expert Rev Clin Immunol 2013, 9: 43–51.

    Article  PubMed  CAS  Google Scholar 

  9. Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Cline Endocrinol Metab 1998, 83: 1049–55.

    Article  CAS  Google Scholar 

  10. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006, 91: 2843–50.

    Article  PubMed  CAS  Google Scholar 

  11. Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Inter Med 2009, 265: 514–29.

    Article  CAS  Google Scholar 

  12. Ulinski T, Perrin L, Morris M, et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. J Clin Endocrinol Metab 2006, 91: 192–5.

    Article  PubMed  CAS  Google Scholar 

  13. Capalbo D, Elefante A, Spagnuolo MI, et al. Posterior reversible encephalopathy syndrome in a child during an accelerated phase of a severe APECED phenotype due to an uncommon mutation of AIRE. Clin Endocrinol (Oxf) 2008, 69: 511–3.

    Article  Google Scholar 

  14. De Luca F, Valenzise M, Alaggio R, et al. Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and lethal lung disease in one of the affected brothers. Eur J Pediatr 2008, 167: 1283–8.

    Article  PubMed  CAS  Google Scholar 

  15. Alimohammadi M, Dubois N, Skoldberg F, et al. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. Proc Natl Acad Sci U S A 2009, 106: 4396–401.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Valenzise M, Meloni A, Betterle C, et al. Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal distrophy. Eur J Pediatr 2009, 168: 237–40.

    Article  PubMed  Google Scholar 

  17. Al-Owain M, Kaya N, Al-Zaidan, et al. Renal failure associated with APECED and terminal 4q deletion: evidence of autoimmune nephropathy. Clin Dev Immunol 2010, 2010: 586342.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  18. Popler J, Alimohammadi M, Kampe O, et al. Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr Pulmonol 2012, 47: 84–7.

    Article  PubMed  Google Scholar 

  19. Capalbo D, Fusco A, Aloj G, et al. High intrafamilial variability in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case study. J Endocrinol Invest 2012, 35: 77–81.

    PubMed  CAS  Google Scholar 

  20. Capalbo D, Giardino G, Martino LD, et al. Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations. Int Rev Immunol 2012, 31: 344–62.

    Article  PubMed  CAS  Google Scholar 

  21. Mazza C, Buzi F, Ortolani F et al. Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin Immunol 2011, 139: 6–11.

    Article  PubMed  CAS  Google Scholar 

  22. Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann N Y Acad Sci 2011, 1246: 77–91.

    Article  PubMed  CAS  Google Scholar 

  23. Conti HR, Shen F, Nayyar N, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206: 299–311.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  24. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndrome: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002, 23: 327–64.

    Article  PubMed  CAS  Google Scholar 

  25. Al-Azem H, Khan AA. Hypoparathyroidism. Best Pract Clin Endocrinol Metab 2012, 26: 517–22.

    Article  CAS  Google Scholar 

  26. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndrome (APS). Acta Biomed 2003, 74: 9–33.

    PubMed  Google Scholar 

  27. Shulman DI, Palmert MR, Kemp SF; Lawson Wilkins Drug and therapeutics Committee. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 2007, 119: e484–94.

    Article  PubMed  Google Scholar 

  28. Barkan AL, Kelch RP, Marshall JC. Isolated gonadotrope failure in the polyglandular autoimmune syndrome. N Engl J Med 1985, 312: 1535–40.

    Article  PubMed  CAS  Google Scholar 

  29. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992, 29: 824–6.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Meloni A, Willcox N, Meager, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 2012, 97: 1114–24.

    Article  PubMed  CAS  Google Scholar 

  31. Wolff AS, Erichsen MM, Meager A, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007, 92: 595–603.

    Article  PubMed  CAS  Google Scholar 

  32. Radetti G, Maselli M, Buzi F, et al. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocinol (Oxf) 2012, 76: 394–8.

    Article  CAS  Google Scholar 

  33. Cerbone M, Bravaccio C, Capalbo D, et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol 2012, 164: 591–7.

    Article  CAS  Google Scholar 

  34. Wasniewska M, Corrias A, Aversa T, et al. Comparative evaluation of therapy with L-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism. Horm Res Paediatr 2012, 77: 376–81.

    Article  PubMed  CAS  Google Scholar 

  35. Cerbone M, Agretti P, De Marco G, et al. Non-autoimmune subclinical hypothyroidism due to a mutation in TSH receptor: report on two brothers. Ital J Pediatr 2013, 39: 5.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  36. Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A. Lymphocytic hypophysitis; a rare or underestimated disease? Eur J Endocrinol 2003, 149: 363–76.

    Article  PubMed  CAS  Google Scholar 

  37. De Bellis A, Salerno M, Ilmarinen T, et al. Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature. J Clin Endocrinol Metab 2006, 91: 2484–9.

    Article  PubMed  CAS  Google Scholar 

  38. De Bellis A, Ruocco G, Battaglia M, et al. Immunological and clinical aspects of lymphocytic hypophysitis. Clin Sci (Lond) 2008, 114: 413–21.

    Article  CAS  Google Scholar 

  39. Capalbo D, De Martino L, Giardino G, et al. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation. Int J Endocrinol 2012, 353250; doi: 10.1155/2012/353250.

  40. Merenmies L, Tarkkanen A. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis. Acta Ophthalmol Scand 2000, 78: 532–5.

    Article  PubMed  CAS  Google Scholar 

  41. Kluger N, Jokinen M, Krohn K, Ranki A. Gastrointestinal Manifestations in APECED Syndrome. J Clin Gastroenterol 2013, 47: 112–20.

    Article  PubMed  CAS  Google Scholar 

  42. Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51: 2193–213.

    Article  PubMed  CAS  Google Scholar 

  43. Kisand K, BoeWolff AS, Podkrajsek KT, et al. Chronic mucocutaneous candidiasis in APECED orthymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010, 207: 299–308.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  44. Puel A, Doffinger R, Natividad A, et al. Autoantibodies against IL-17A, IL-17 F and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010, 207: 291–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  45. Lindh E, Brannström J, Jones P, et al. Autoimmunity and cystatin SA1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1. J Autoimmun 2012, doi: 10.1016/j.jaut.2012.10.001.

  46. Alimohammadi M, Bjorklund P, Hallgren A, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 2008, 358: 1018–28.

    Article  PubMed  CAS  Google Scholar 

  47. Otsuka N, Tong ZB, Vanevski K, Tu W, Cheng MH, Nelson LM. Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of mater. Endocrinology 2011, 152: 2465–73.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  48. Soderbergh A, Myhre AG, Ekwall O, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004, 89: 557–62.

    Article  PubMed  CAS  Google Scholar 

  49. Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF, Weetman AP. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2007, 92: 2107–14.

    Article  PubMed  CAS  Google Scholar 

  50. Coco G, Dal Pra C, Presotto F, et al. Estimated risk for developing autoimmune Addison’s disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006, 91: 1637–45.

    Article  PubMed  CAS  Google Scholar 

  51. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997, 18: 107–34.

    PubMed  CAS  Google Scholar 

  52. Reato G, Morlin L, Chen S, et al. Premature ovarian failure in patients with autoimmune Addison’s disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab 2011, 96: e1255–61.

    Article  PubMed  CAS  Google Scholar 

  53. Reimand K, Perheentupa J, Link M, Krohn K, Peterson P, Uibo R. Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I. Int Immunol 2008, 20: 39–44.

    Article  PubMed  CAS  Google Scholar 

  54. Husebye ES, Anderson MS. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. Immunity 2010, 32: 479–87.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  55. Hedstrand H, Ekwall O, Olsson MJ, et al. The transcription factors SOX9 and SOX10 are vitiligoautoantigens in autoimmune polyendocrine syndrome type 1. J Biol Chem 2001, 276: 35390–5.

    Article  PubMed  CAS  Google Scholar 

  56. Ekwall O, Hedstrand H, Grimelius L, et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998, 352: 279–83.

    Article  PubMed  CAS  Google Scholar 

  57. Gianani R, Eisenbarth GS. Autoimmunity to gastrointestinal endocrine cells in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2003, 88: 1442–4.

    Article  PubMed  CAS  Google Scholar 

  58. Dal Pra C, Chen S, Betterle C, et al. Autoantibodies to human tryptophan hydroxylase and aromatic L-amino acid decarboxylase. Eur J Endocrinol 2004, 150: 313–21.

    Article  Google Scholar 

  59. Scarpa R, Alaggio R, Norberto L, et al. Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2013, 98: 704–12.

    Article  PubMed  CAS  Google Scholar 

  60. Skoldberg F, Portela-Gomes GM, Grimelius L, et al. Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. J Clin Endocrinol Metab 2003, 88: 1445–52.

    Article  PubMed  CAS  Google Scholar 

  61. Clemente MG, Obermayer-Straub P, Meloni A, et al. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1997, 82: 1353–61.

    PubMed  CAS  Google Scholar 

  62. Gebre-Medhin G, Husebye ES, Gustafsson J, et al. Cytochrome P450IA2 and aromatic l-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett 1997, 412: 439–45.

    Article  PubMed  CAS  Google Scholar 

  63. Clemente MG, Meloni A, Obermayer-Straub P, Frau F, Manns MP, De Virgiliis S. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1. Gastroenterology 1998, 114: 324–8.

    Article  PubMed  CAS  Google Scholar 

  64. Su MA, Davini D, Cheng P, et al. Defective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathy. J Immunol 2012, 188: 4906–12.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  65. Meager A, Visvalingam K, Peterson P, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006, 3: e289.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  66. Meloni A, Furcas M, Cetani F, et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2008, 93: 4389–97.

    Article  PubMed  CAS  Google Scholar 

  67. Ahonen P, Myllärniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990, 322: 1829–36.

    Article  PubMed  CAS  Google Scholar 

  68. Aaltonen J, Bjorses P, Sandkuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet 1994, 8: 83–7.

    Article  PubMed  CAS  Google Scholar 

  69. Rosatelli MC, Meloni A, Meloni A, et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Gen 1998, 103: 428–34.

    Article  CAS  Google Scholar 

  70. Capalbo D, Mazza C, Giordano R, et al. Molecular background and genotype-phenotype correlation in autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy patients from Campania and in their relatives. J Endocrinol Invest 2012, 35: 169–73.

    PubMed  CAS  Google Scholar 

  71. Meloni A, Perniola R, Faà V, Corvaglia E, Cao A, Rosatelli MC. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J Clin Endocrinol Metab 2002, 87: 841–6.

    Article  PubMed  CAS  Google Scholar 

  72. Cervato S, Mariniello B, Lazzarotto F, et al. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectoderaml-dystrophy (APECED) and in their relatives. Clin Endocrinol 2009, 70: 421–8.

    Article  Google Scholar 

  73. Cetani F, Barbesino G, Borsari S, et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectoderma dystrophy, acting in a dominant fashion and strongly consegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001, 86: 4747–52.

    Article  PubMed  CAS  Google Scholar 

  74. Scott HS, Heino M, Peterson P, et al. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol 1998, 12: 1112–9.

    Article  PubMed  CAS  Google Scholar 

  75. Podkrajsek KT, Bratanic N, Krzisnik C, Battelino T. Autoimmune regulator-1 messenger ribonucleic acid analysis in a novel intronic mutation and two additional novel AIRE gene mutations in a cohort of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. J Clin Endocrinol Metab 2005, 90: 4930–5.

    Article  PubMed  CAS  Google Scholar 

  76. Stolarski B, Pronicka E, Korniszewski L, et al. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet 2006, 70: 348–54.

    Article  PubMed  CAS  Google Scholar 

  77. Pearce SH, Cheetham T, Imrie H, et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998, 63: 1675–84.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  78. Dominguez M, Crushell E, Ilmarinen T, et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in the Irish population. J Pediatr Endocrinol Metab 2006, 19: 1343–52.

    Article  PubMed  CAS  Google Scholar 

  79. Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD, She JX. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum Genet 1998, 103: 681–5.

    Article  PubMed  CAS  Google Scholar 

  80. Heino M, Scott HS, Chen Q, et al. Mutation analyses of North American APS-1 patients. Hum Mutat 1999, 13: 69–74.

    Article  PubMed  CAS  Google Scholar 

  81. Björses P, Halonen M, Palvimo JJ, et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrine-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000, 66: 378–92.

    Article  PubMed Central  PubMed  Google Scholar 

  82. Giordano C, Modica R, Allotta ML, et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) in Sicily: confirmation that R203X is the peculiar AIRE gene mutation. J Endocrinol Invest 2012, 35: 384–8.

    PubMed  CAS  Google Scholar 

  83. Valenzise M, Wasniewska M, Mirabelli S, De Luca F, Cervato S, Betterle C. Identification of two novel mutations in the first Sicilian APECED with no R203X mutation in AIRE gene and review of Italian APECED genotypes. Gene 2012, 499: 343–6.

    Article  PubMed  CAS  Google Scholar 

  84. Betterle C, Ghizzoni L, Cassio A, et al. Autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy in Calabria: clinical, immunological and genetic patterns. J Endocrinol Invest 2012, 35: 877–81.

    PubMed  CAS  Google Scholar 

  85. Rautemaa R, Richardson M, Pfaller M, Koukila-Kahkola P, Perheentupa J, Saxen H. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother 2007, 60: 889–92.

    Article  PubMed  CAS  Google Scholar 

  86. Firinu D, Massidda O, Lorrai MM, et al. Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole. Clin Dev Immunol 2011, 2011: 283239.

    Article  PubMed Central  PubMed  Google Scholar 

  87. Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenge for future research. J Bone Miner Res 2011, 26: 2317–37.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  88. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med 2008, 359: 391–403.

    Article  PubMed  CAS  Google Scholar 

  89. Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1–34 versus calcitriol and calcium. J Clin Endocrinol Metab 2010, 95: 2680–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  90. Hindmarsh PC. How do you initiate oestrogen therapy in a girl who has not undergone puberty? ClinEndocrinol 2009, 71: 7–10.

    CAS  Google Scholar 

  91. Bertelloni S, Baroncelli GI, Garofalo P, Cianfarani S. Androgen therapy in hypogonadal adolescentmales. Horm Res Paediatr 2010, 74: 292–6.

    Article  PubMed  CAS  Google Scholar 

  92. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guidelines. J Clin Endocrinol Metab 2006, 91: 1995–2010.

    Article  PubMed  CAS  Google Scholar 

  93. Bhasin S, Basaria S. Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab 2011, 25: 251–70.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Salerno MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Capalbo, D., Improda, N., Esposito, A. et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective. J Endocrinol Invest 36, 903–912 (2013). https://doi.org/10.3275/8999

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8999

Key-words

Navigation